The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Cauldstream7,
You seem to have blown out of all proportions the relationship between IMM and the CNRS …
They are both co owners of the P140 patents whilst IMM has the commercial rights to advance the clinical trials / marketing etc
The CNRS is a major European research institute and the Imm connexion is only one of many thousands of programs in which they participate….
Pokerchips,
No adjustments were made for them…
There is a big difference between the talk and the actual money spent by Avion since they signed up with IMM ( no upfront payment either )
Talk is cheap Lambo222 but reality is reality
Pokerchips,
As you know, Landstead have a ten year expiration date on their warrants/options so they may wait quite a while before exercising them , imo … ( they may be more inclined to sell into any strong rise whilst hedging their current shareholdings ??
L1 and Lind only have until the 10/06 to exercise their options , so logically my focus will be on them for the immediate future .
Best regards
Lambo222,
You won’t find me on Twitter and I don’t do money bets with people I don’t know:-)
Great to see you so confident and optimistic, so that must mean you won’t be selling out at 5p if it goes positively with the FDA on the P2-P3 adoptive trials ?
Being so optimistic, you seem to overlook many of the potholes on the journey, but I am sure you will see them when you have sold out …
Best regards and as I usually say ´ Eyes to the sky, but feet on the ground «
Lambo222 ,
I think we already know that you ´ pump and dump ´ for profit , that is quite plain to all …
Write whatever you like , it’s a free world , but it would be nice, every now and again to have a measured analysis and not just biased posts to further your buying or selling activities .
I wonder who wrote this a few days ago ??
´ It’s all about the FDA decision on 7th June, it will
Take balls of steal to hold for the result given it’s a whole new protocol and phase2/3 adaptive trial FDA may want to see the dosing data first before allowing phase 3, as ever with IMM the swings are wild you can be up 50% one minute and down 50% the next…nature of the beast ´
Two sides to the every coin so one should be measured in their analysis and not just pumping when one is ´ in ´ whilst very critical when on the sidelines :-)
Lambo222,
It’s all good fun but one has to be a minimum logical
Because even you know that when you write predictions such as ´ could easily 3-4 times their money over the next few weeks´ That is just plain pumping and the odds are 1/1000 of that happening
Scoredagainststeps,
You’re very conservative with your 8p estimate , imo but everyone to their own as per usual :-)
Wild bunch ,
For those who have bought in recently and have averages of less than 5p, 20% dilution won’t really bother them, imo but my comment was for LT …
There are many more options and warrants which have extended expiry dates but that’s another story …
Going to be an interesting month of June for all holders in any case !
Lordloadsoflolly,
The Newsflow in the coming weeks will help them to decide to exercise or not their options …
If they are exercised it will put a few million in the bank for IMM but will have a major dilutive effect on the LT Private investors , imo